Evaluation of clinical and safety outcomes of cancer vaccines in patients with advanced non-small cell lung cancer after first-line therapy: a systematic review and meta-analysis
Authors:
- Shaoyi ChenSCShaoyi Chen
- Zewen SunZSZewen Sun
- Yun LiYLYun Li
- Fan YangFYFan Yang
- Peiyu WangPWPeiyu Wang
- Kezhong ChenKCKezhong Chen
- Jun WangJWJun Wang
- Mantang QiuMQMantang Qiu
Open Access
- 24 July 2025
- journal article
- review article
- Published by Elsevier in eClinicalMedicine
- Vol. 86
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2023YFF0723500)
- Peking University (RZ2022-04)
- National Natural Science Foundation of China (82173386)
- Chinese Academy of Medical Sciences (2021RU002)
- Beijing Nova Program (20240484580)
- Beijing Nova Program (20230484314)
This publication has 36 references indexed in Scilit:
- The current therapeutic cancer vaccines landscape in non‐small cell lung cancerInternational Journal of Cancer, 2024
- Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventionsAgeing Research Reviews, 2024
- Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1Annals of Oncology, 2023
- Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancerCancer Cell, 2022
- The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysiseClinicalMedicine, 2021
- Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancerLung Cancer, 2017
- A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancerEuropean Journal of Cancer, 2015
- Radiotherapy and Immunogenic Cell DeathSeminars in Radiation Oncology, 2015
- Therapeutic vaccination for non-small-cell lung cancer: a meta-analysisMedical Oncology, 2014
- Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trialJournal of Cancer Research and Clinical Oncology, 2011